Stop TB USA
stoptbusa.org
leadership@stoptbusa.org
PO Box 260288, Atlanta, GA 31126 USA

TB IN THE NEWS

TB Incidence Reports: 

• Active tuberculosis case confirmed at Lakeville South High School, but officials say there's no further risk
  
• Tuberculosis cases in Georgia dropped in 2023, bucking the national trend
  
• Louisiana drops lawsuit after inmates exposed to rare kind of tuberculosis medically cleared
  
• Arkansas seeing record-setting tuberculosis case numbers
  ​​​
  

TB Articles:

• How cigarettes and chocolates helped to tackle a TB epidemic
  
• Study finds tuberculosis changes liver metabolism and could promote diabetes
  
• 'Achilles heel' of drug-resistant pathogens
  
• Researchers reveal why a key tuberculosis drug works against resistant strains
  
• Inclusion for every child: reaching every child affected by tuberculosis
  
• ERA4TB accelerates the development of new treatment regimens for tuberculosis.
  
• For People Living with HIV/AIDS, TB is Still the Leading Cause of Death
  
• Ocular tuberculosis and relapse rates for recurrence of uveitis
  
• End TB Now Act can show national unity 
  
• John Green’s crusade to make the world “suck less”

Read lots more TB news on our website page  ‘From TB Wire’!

TB RESOURCES & REPORTS

​

• Global Tuberculosis Report 2024
  
• Reported Tuberculosis in the United States, 2023
  
• Communicable disease threats report, 16-22 November 2024, week 47
  
• USAID’s Global Tuberculosis (TB) Strategy 2023–2030
  
• TB continues to be the world’s leading infectious disease killer: WHO Global TB Report 2024
  
• Digital TB Surveillance System Assessment Report
  ​
  

Find more TB resources on our website page ‘TB Resources’!​

​​​​​Stop TB USA: Where we unite to #EndTB!

Invite a friend to sign up to receive the TB Wire and be a part of Stop TB USA!

​Donate Now! https://donatenow.networkforgood.org/stop-tb-usa

December 2024 WORK IN PROGRESS

​

GREETINGS FROM THE CHAIR
​I am not going to lie; I love listening to Christmas music. It puts me in a good mood, but I also get a bit
nostalgic at the fact that the year is ending. How will you end your year? We recommend acting to
#EndTB and end the year on a high note. Here are some ideas: 1. Donate to Stop TB USA; 2. Nominate
someone to be our new Chair Elect and/or Secretary; and 3. Call your Representative to ask them to urge
leadership to pass the End TB Now Act.
- Cynthia A. Tschampl, PhD, Chair

- Cynthia A. Tschampl, PhD, Chair

JOURNAL ARTICLES

• Trends and annual percentage changes in tuberculosis mortality estimated by Joinpoint regression and age-period-cohort analyses, Taiwan, 1978–2022
  
• Mycobacterium tuberculosis infection in pregnancy: A systematic review
  
• Study finds weakness in drug-resistant tuberculosis pathogens
  
• “Oh, That Still Exists?” – An Overview of Tuberculosis and Its Effects on the Pediatric Population in America
  
• A Novel Actinobacteria-Specific Ribosome Hibernation Factor in Mycobacterium tuberculosis
  

Discover many more peer-reviewed articles on our website page ‘Peer-Reviewed Publications’!​

​​​

TB BOOKSHELF

​This is the research poster presented at APHA by Alina Cernasev and Aishva Kothari from the Stop TB USA Pharmacy Work Group, which shines a spotlight on the urgent need for pharmacy-driven TB interventions to combat drug shortages and strengthen prevention efforts.

 Stop TB USA

© Copyright. All Rights Reserved

TB Wire past issues: 2024, 2023, 2022 

​​​EVENTS, CONFERENCES, & COURSES  

​

• Stop TB USA - Media Advocacy Training (12/12/24)
  
• 20th International Congress on Infectious Diseases (ICID) | December 3-6
  
• Tuberculosis: Heterogeneity from Experimental Models to Human Disease | February 16-19, 2025
  
• Monthly |SEATRAC Seminar Series
  
• Inaugural Annual WGNV Meeting

2023 Tuberculosis (TB) Surveillance Report Now Available 
​

• CDC’s annual TB surveillance report, Reported Tuberculosis in the United States, 2023 is now available exclusively online. The number of reported TB disease cases and incidence rate increased in 2023 for the third year since 2020, surpassing pre-COVID-19 pandemic levels. CDC created a slide set and infographic to highlight findings from the 2023 surveillance report. 
  

​TBESC-II Parts A and B Online 

• The Tuberculosis Epidemiologic Studies Consortium (TBESC)-II operated from 2011 to 2021 to enhance strategies for latent TB diagnosis and treatment. It conducted three studies: Parts A, B, and C, with Parts A and B currently available online. Part A compared three TB infection tests in high-risk populations, and Part B examined the TB prevention care cascade in clinics.  

​

​

​

DC UPDATE

We are in the final days of the 118 th Congress! While the End TB Now Act of 2023 passed the Senate in
September, we need to keep asking to our House members to co-sponsor the bill and to speak with
leadership to add it to the suspension calendar so it can pass before year’s end!! Looking toward next year,
save April 9/10 for the annual TB Hill Day (and plan to see us in DC!).

Here are the asks for your Members of Congress:

1. (House members only:) Co-sponsor the End TB Now Act, H.1776/S.288! [Here’s a helpful fact sheet and a press release about the End TB Now Act.] Sample script: As your constituent and a global health advocate, I urge you to support the bipartisan End Tuberculosis Now Act (H.R.1776) being led by Reps. Bera and Salazar. The Senate just passed their companion bill via unanimous consent - and we are urging the House Leadership to put this bill on thesuspension calendar for a vote as soon as possible.
   ​
   
2. Write a letter to CMS Administrator Brooks-LaSure in support of a **timely** National Coverage Determination of LTBI screening and testing. Get more information here.
   
   

Pro tip: Call the Capitol Switchboard at 1-202-224-3121 and ask for your senator/representative or give your state if you do not know their name. When you are connected to an office, ask for the Health Legislative Assistant. If you leave a voicemail message, include your name, phone number, and email so that they can respond. If you would like a sample script, email us at leadership@stoptbusa.org. Bonus points if you write us at leadership@stoptbusa.org and tell us how your call went!!

ANNOUNCEMENTS

• Tuberculosis resurges as top infectious disease killer
  
• TB reclaims title of deadliest infectious disease. That's an 'outrage' says WHO
  
• Global Fund and Stop TB Step Up Collaboration to Fight Tuberculosis, the Biggest Infectious Disease Killer
  
• MSF calls for urgent action as governments and donors are failing children with TB
  
• TB Surpasses COVID-19 as Top Cause of Infectious Disease Deaths
  

Other Opportunities: 

• Notice of CDC Funding Opportunity Announcement
• Call for case studies and best practices on addressing tuberculosis in prisons
  
• National Institute of Allergy and Infectious Disease (NIAID)​​​​​addressing reported drug shortage challenges for U.S. TB
  

programs.
-FDA updated its Drug Shortage Reportto include isoniazid (INH)on 05/23/23.View the report here.2023-2024 TEA Mini-Grant Program RFP and Information Session Open Now!Applications dueJune 16th, 2023.
-CDC recently published a“Dear Colleague Letter”addressing reported drug shortage challenges for U.S. TB
programs.
-FDA updated its Drug Shortage Reportto include isoniazid (INH)on 05/23/23.View the report here.2023-2024 TEA Mini-Grant Program RFP and Information Session Open Now!Applications dueJune 16th, 2023.
-CDC recently published a“Dear Colleague Letter”addressing reported drug shortage challenges for U.S. TB
programs.
-FDA updated its Drug Shortage Reportto include isoniazid (INH)on 05/23/23.View the report here.2023-2024 TEA Mini-Grant Program RFP and Information Session Open Now!Applications dueJune 16th, 2023.
-CDC recently published a“Dear Colleague Letter”addressing reported drug shortage challenges for U.S. TB
programs.
-FDA updated its Drug Shortage Reportto include isoniazid (INH)on 05/23/23.View the report here.